In the last 12 months, insiders at ADIAL PHARMACEUTICALS, INC. ($ADIL) filed 30 transactions with the SEC: 1 open-market purchases totaling $1,918 and 0 sales totaling $0. Net insider sentiment: net buying.
ADIAL PHARMACEUTICALS, INC. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- Schuyler Kevin (Director) — 4 transactions totaling $1,918
- Shah Vinay (Chief Financial Officer) — 2 transactions totaling $0
- Stilley William B. III (Director) — 3 transactions totaling $0
- Johnson Bankole A. (Director) — 1 transaction totaling $0
- Newman James W. Jr. (Director) — 3 transactions totaling $0
View all SEC Filings for ADIAL PHARMACEUTICALS, INC. (ADIL).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| May 29, 2025 | Gilliland Robertson H. | Director | A | Stock Option (Right to Buy) | 28000 | $0.00 | 28,000.0000 | 6,539,760 | 9999.99% | 0.43% |
| May 29, 2025 | Newman James W. Jr. | Director | A | Stock Option (Right to Buy) | 28000 | $0.00 | 28,000.0000 | 6,539,760 | 9999.99% | 0.43% |
| May 29, 2025 | Shah Vinay | Chief Financial Officer | A | Stock Option (Right to Buy) | 9000 | $0.00 | 9,000.0000 | 6,539,760 | 9999.99% | 0.14% |
| May 29, 2025 | Schuyler Kevin | Director | A | Stock Option (Right to Buy) | 28000 | $0.00 | 28,000.0000 | 6,539,760 | 9999.99% | 0.43% |
| May 29, 2025 | Claiborne Cary J | Chief Executive Officer | A | Stock Option (Right to Buy) | 138000 | $0.00 | 138,000.0000 | 6,539,760 | 9999.99% | 2.11% |
| May 29, 2025 | Goodman Tony | Chief Operating Officer | A | Stock Option (Right to Buy) | 94000 | $0.00 | 94,000.0000 | 6,539,760 | 9999.99% | 1.44% |
| May 29, 2025 | Anderson J. Kermit | Director | A | Stock Option (Right to Buy) | 28000 | $0.00 | 28,000.0000 | 6,539,760 | 9999.99% | 0.43% |
| Dec. 5, 2024 | Claiborne Cary J | Chief Executive Officer | A | Stock Option (Right to Buy) | 350000 | $0.00 | 350,000.0000 | 5,835,682 | 9999.99% | 6.00% |
| Nov. 16, 2024 | Shah Vinay | Chief Financial Officer | A | Stock Option | 40000 | $0.00 | 40,000.0000 | 5,835,682 | 9999.99% | 0.69% |
| March 25, 2024 | Gilliland Robertson H. | Director | A | Stock Option (Right to Buy) | 12000 | $0.00 | 12,000.0000 | 1,424,661 | 9999.99% | 0.84% |
| March 25, 2024 | Newman James W. Jr. | Director | A | Stock Option (Right to Buy) | 12000 | $0.00 | 12,000.0000 | 1,424,661 | 9999.99% | 0.84% |
| March 25, 2024 | Truluck Joseph | Chief Financial Officer | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 1,424,661 | 9999.99% | 1.75% |
| March 25, 2024 | Claiborne Cary J | Chief Executive Officer | A | Stock Option (Right to Buy) | 60000 | $0.00 | 60,000.0000 | 1,424,661 | 9999.99% | 4.21% |
| March 25, 2024 | Anderson J. Kermit | Director | A | Stock Option (Right to Buy) | 12000 | $0.00 | 12,000.0000 | 1,424,661 | 9999.99% | 0.84% |
| March 25, 2024 | Schuyler Kevin | Director | A | Stock Option (Right to Buy) | 12000 | $0.00 | 12,000.0000 | 1,424,661 | 9999.99% | 0.84% |
| March 25, 2024 | Goodman Tony | Chief Operating Officer | A | Stock Option (Right to Buy) | 42000 | $0.00 | 42,000.0000 | 1,424,661 | 9999.99% | 2.95% |
| Sept. 29, 2023 | Schuyler Kevin | Director | P | Common Stock | 700 | $2.74 | 6,589.0000 | 1,131,436 | 11.89% | 0.06% |
| May 23, 2023 | Johnson Bankole A. | Director | A | Stock Option | 40000 | $0.00 | 40,000.0000 | 26,463,559 | 9999.99% | 0.15% |
| May 23, 2023 | Truluck Joseph | Chief Financial Officer | A | Common Stock | 157500 | $0.00 | 265,139.0000 | 26,463,559 | 146.32% | 0.60% |
| May 23, 2023 | Truluck Joseph | Chief Financial Officer | A | Stock Option (Right to Buy) | 125000 | $0.00 | 125,000.0000 | 26,463,559 | 9999.99% | 0.47% |
| May 23, 2023 | Stilley William B. III | Director | A | Common Stock | 240800 | $0.00 | 1,261,779.0000 | 26,463,559 | 23.59% | 0.91% |
| May 23, 2023 | Stilley William B. III | Director | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 26,463,559 | 9999.99% | 0.19% |
| May 23, 2023 | Schuyler Kevin | Director | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 26,463,559 | 9999.99% | 0.19% |
| May 23, 2023 | Newman James W. Jr. | Director | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 26,463,559 | 9999.99% | 0.19% |
| May 23, 2023 | Goodman Tony | Director | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 26,463,559 | 9999.99% | 0.19% |
| May 23, 2023 | Gilliland Robertson H. | Director | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 26,463,559 | 9999.99% | 0.19% |
| May 23, 2023 | Claiborne Cary J | Chief Executive Officer | A | Common Stock | 420000 | $0.00 | 1,520,000.0000 | 26,463,559 | 38.18% | 1.59% |
| May 23, 2023 | Claiborne Cary J | Chief Executive Officer | A | Stock Option (Right to Buy) | 300000 | $0.00 | 300,000.0000 | 26,463,559 | 9999.99% | 1.13% |
| May 23, 2023 | Anderson J. Kermit | Director | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 26,463,559 | 9999.99% | 0.19% |
| Dec. 30, 2022 | Stilley William B. III | Director | D | Common Stock | 166667 | $0.00 | 1,020,979.0000 | 1,028,982 | 14.03% | 16.20% |